Pulse pressure identified as important risk factor for atrial fibrillationFebruary 21, 2007Increased pulse pressure (the difference between systolic and diastolic blood pressure) appears to be an important predictor of the risk for new onset atrial fibrillation, according to a study in the February 21 issue of JAMA. Atrial fibrillation (AF) is the most common chronic arrhythmia in adults and is associated with increased risk for death and stroke. An estimated 2.3 million adults in the United States have AF, and that number is expected to increase substantially as the population ages, making identification of modifiable risk factors important. The prevalence of AF increases with age, with a substantial overall lifetime risk of approximately 1 in 4 for both men and women, according to background information in the article. The increase in AF incidence with age coincides with a rapid age-related increase in aortic stiffness, which is associated with increased pulse pressure, which increases cardiac load and may increase AF risk. Gary F. Mitchell, M.D., of Cardiovascular Engineering Inc., Waltham, Mass., and colleagues examined the association between pulse pressure and the development of AF. The study included 5,331 participants of the Framingham Heart Study who were age 35 years and older and initially free from AF (median [midpoint] age, 57 years; 55 percent women). During an average of 16 years of follow-up, 363 men and 335 women developed AF with a median time-to-event of 12 years after pulse pressure assessment. The researchers found that after adjusting for age and sex, a 20 mm Hg increase in pulse pressure was associated with a 34 percent increase in the risk for developing AF. The association between pulse pressure and AF remained significant after further adjusting for average arterial pressure and clinical risk factors for AF; each 20 mm Hg increase in pulse pressure was associated with a 24 percent increase in the risk for developing AF. In contrast, average arterial pressure was not associated with increased risk for developing AF. Cumulative 20-year AF incidence rates were 5.6 percent for pulse pressure of 40 mm Hg or less (25th percentile) and 23.3 percent for pulse pressure greater than 61 mm Hg (75th percentile). "In summary, we have shown that increased pulse pressure, a simple and readily accessible if somewhat indirect measure of arterial stiffness, is likely an important risk factor for development of AF in a community-based sample. Arterial stiffness increases with advancing age, even in a relatively healthy sample. However, increased arterial stiffness with advancing age is not inevitable and appears to be modifiable [such as by reducing various cardiovascular disease risk factors]. As a result, increased arterial stiffness may represent a major modifiable risk factor for development of AF." "Given the aging of the population, further research is needed to determine whether interventions aimed at reducing pulse pressure or preventing the increase in pulse pressure with advancing age effectively reduce the incidence of AF. In light of the variable and often substantial increase in pulse pressure that accompanies advancing age, lifestyle modifications or therapy aimed specifically at reducing or limiting the increase in pulse pressure with advancing age may markedly reduce the substantial and rapidly growing incidence of AF in our aging society," the authors write. JAMA and Archives Journals |
|||||||||||||||||||||
| Related Atrial Fibrillation Current Events and Atrial Fibrillation News Articles Size matters: Obesity leading risk factor of left atrial enlargement during aging Aside from aging itself, obesity appears to be the most powerful predictor of left atrial enlargement (LAE), upping one's risk of atrial fibrillation (the most common type of arrhythmia), stroke and death. Experts unveil new CVD guidelines and position papers Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week. Learning the risks for stroke - and taking action With this theme in mind, the European Society of Cardiology (ESC) emphasises that most of the risks for stroke are also the major risks for coronary heart disease - and thus the object of the ESC's far-reaching prevention programme. Afib triggered by a cell that resembles a pigment-producing skin cell The source and mechanisms underlying the abnormal heart beats that initiate atrial fibrillation (Afib), the most common type of abnormal heart beat, have not been well determined. New blood-thinning drug safer than rat poison In an article reviewed by F1000 Medicine Faculty Members Robert Ruff, Brian Olshansky and Luis Ruilope, the blood-thinner dabigatran is shown to protect against stroke, blood clotting and major bleeding as effectively as warfarin, but with fewer side effects. Women with diabetes at increased risk for irregular heart rhythm Diabetes increases by 26 percent the likelihood that women will develop atrial fibrillation (AF), a potentially dangerous irregular heart rhythm that can lead to stroke, heart failure, and chronic fatigue. Women with Atrial Fibrillation Are at Significantly Higher Risk of Stroke and Death Compared to Men and Receive Less Attention Even though the incidence of atrial fibrillation is higher in men than women, a review of past studies and medical literature completed by cardiac experts at Rush University Medical Center shows that women are more likely than men to experience symptomatic attacks, a higher frequency of recurrences, and significantly higher heart rates during atrial fibrillation, which increases the risk of stroke. Mount Sinai first in nation to ablate atrial fibrillation using new visually-guided balloon catheter Physicians at The Mount Sinai Medical Center in New York became the first in the U.S. to ablate atrial fibrillation using a visually-guided laser balloon catheter. Atrial fibrillation: Drugs or ablation? Atrial fibrillation ablation is one of the fastest growing techniques in cardiology and due to the very high number of patients that might be candidates to this procedure, a significant number of resources will have to be devoted to it to be able to treat them in the following years. Irbesartan reduces heart failure in patients with quivering heart Most research in atrial fibrillation (AF) has focused on reducing stroke and other embolic events. Yet heart failure occurs more frequently in AF patients, but has not been the focus of intervention research. More Atrial Fibrillation Current Events and Atrial Fibrillation News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||